Markets

BF Biosciences plans to sell 28.3% shares in a public offering

Company targets raising PKR 1.4 billion

BF Biosciences plans to sell 28.3% shares in a public offering

A view of BF Biosciences office

Ferozsons Laboratories Website

BF Biosciences Limited plans to issue 25 million shares, representing 28.3% of its post-IPO paid-up capital, at a floor price of PKR 55.0 per share. The total transaction size will be PKR 1,375 million ($4.9 million) at the floor price and PKR 1,925 million at the cap price of PKR 77.0 per share.

The offering will be conducted through a 100% book-building process, where bidders will place bids for the full issue size. However, only 75% of the shares will be allocated to successful bidders, with the remaining 25% reserved for retail investors. If the retail portion is undersubscribed, the remaining shares will be distributed pro-rata among the successful bidders.

The funds raised from the IPO will be used for:

  • Purchasing plant and machinery to expand the product line and improve process efficiencies.
  • Acquiring export certifications such as PIC/S and SRA, and developing new products like Glucagon-like Peptide (GLP1).
  • Procuring raw and packaging materials to manage working capital needs.

The book-building dates for the IPO are September 25-26, with Arif Habib Limited serving as the lead manager and book runner.

For the first nine months of fiscal year 2024-25, BF Biosciences reported net sales of PKR 2,916 million and a net profit of PKR 314 million, with total assets amounting to PKR 5,882 million. The company has gross margins of 43%, EBITDA margins of 20%, and net margins of 11%.

BF Biosciences is a joint venture between Ferozsons Laboratories Limited and Grupo Empresarial Bagó S.A. The company specializes in the development and manufacture of biotechnology-based pharmaceuticals, particularly in the fields of hepatitis and oncology. Its product range covers therapeutic areas including nephrology, cardiology, gastroenterology, diabetes, oncology, antiviral, and hepatology.

Comments

See what people are discussing

More from Business

Pakistan's short term bonds yield at 30-month low

Pakistan's short term bonds yield at 30-month low

State Bank of raises PKR 568 billion